Re-challenge Immunotherapy With Cromolyn, TQB2102, and Panpulimab in Immune-Refractory Triple Negative Breast Cancer
Clinical trial NCT07419880 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07419880
- Sponsor
- Fudan University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-30
- Primary completion
- 2027-01-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.